ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

Eleven Chemicals Rated for Tests

September 1, 1978

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981